NCT03174275 Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03169335 Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First-line Treatment of Non-squamous Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT03165994 APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers Status COMPLETED Phase PHASE2
NCT03164694 APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLC Status WITHDRAWN Phase PHASE2
NCT03161353 Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03158129 Nivolumab With or Without Ipilimumab or Chemotherapy in Treating Patients With Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT03147040 AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer Status TERMINATED Phase PHASE2
NCT03141359 Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03138889 Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT03134872 A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC Status COMPLETED Phase PHASE3
NCT03134638 A Study of SY-1365 in Adult Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03132532 Platinum Doublet Chemotherapy and Proton Beam Radiation Therapy in Treating Patients With Stage II-III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT03126916 Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) Status RECRUITING Phase PHASE3
NCT03126812 Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03121352 Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT03117049 Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52) Status COMPLETED Phase PHASE3
NCT03107182 Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT03095352 Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease Status COMPLETED Phase PHASE2
NCT03095209 Observation Study of Patients With Non-Small Cell Lung Cancer and Esophageal Cancer Treated With Chemo-Radiation Followed by Surgery Status COMPLETED Phase N/A